Skip to main content
OpenTrials
Completed

NCT Number: NCT07793305

Precision Diabetes Education Guided by Diabetes Complication Risk Assessment

This prospective, multicenter interventional study evaluated the implementation of precision diabetes education guided by individualized diabetes complication risk assessment in adults with type 2 diabetes. The study was conducted at six hospitals in Taiwan.

Participants underwent assessment of their predicted risks for six major diabetes-related complications: diabetic kidney disease, atherosclerotic cardiovascular disease, congestive heart failure, ischemic stroke, diabetic retinopathy, and lower-extremity amputation. Diabetes educators used the risk assessment results to identify the complication with the highest predicted risk and to provide individualized education focused on prevention and modification of relevant health behaviors. Participants continued to receive standard diabetes education and routine clinical care. Personalized education was provided at enrollment and again during follow-up, with clinical information, complication-risk assessment, and patient-reported measures collected during the 6-month study period.

The study aimed to establish a personalized diabetes education model based on complication-risk assessment and to improve the quality of diabetes complication prevention and care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MacKay Memorial Hospital, Taipei, Taiwan

Loading trial locations.

About this study

The study was part of the Precision Diabetes Education program coordinated by the Taiwanese Association of Diabetes Educators and conducted at six participating hospitals in Taiwan. The first part of the study used a prospective, single-group interventional design with a 6-month follow-up period.

After providing written informed consent, participants underwent collection of demographic, clinical, laboratory, medication, and health-behavior information. These data were entered into a diabetes complication risk assessment model developed by investigators from the National Health Research Institutes, Kaohsiung Medical University Hospital, and National Chengchi University. The model estimated individualized absolute and relative risks for six diabetes-related complications: diabetic kidney disease, atherosclerotic cardiovascular disease, congestive heart failure, ischemic stroke, diabetic retinopathy, and lower-extremity amputation.

Based on the risk assessment results, diabetes educators used a standardized education manual to provide individualized education focused primarily on the complication with the highest predicted risk. Participants also continued to receive standard diabetes education and routine clinical care. Personalized education was provided at enrollment and repeated approximately 3 months later. At 6 months, complication-risk assessment, clinical measurements, laboratory data, medication information, and patient-reported measures were reassessed.

The original study protocol did not specify a hierarchy of primary and secondary outcome measures. For retrospective registration, change in hemoglobin A1c from baseline to 6 months was designated as the registry primary outcome; the other outcomes listed in the original protocol are reported as other pre-specified outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older with a diagnosis of type 2 diabetes mellitus and without established chronic diabetes complications.
  • Hemoglobin A1c between 7% and 9%.
  • Stable type and dosage of glucose-lowering medications during the preceding 6 months.
  • Ability to independently understand the study information and procedures and to make an informed decision regarding participation.
  • Willingness to provide written informed consent.

Exclusion criteria

  • Clinically unstable conditions, including acute diabetes-related conditions such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe hypoglycemia, acute infection, or acute organ injury.
  • Terminal illness requiring palliative care or other conditions for which active treatment is no longer appropriate.
  • Unwillingness or inability to provide written informed consent.

Treatment and study plan

Precision Diabetes Education (PDE)

Behavioral

Participants underwent individualized risk assessment for six major diabetes-related complications: diabetic kidney disease, atherosclerotic cardiovascular disease, congestive heart failure, ischemic stroke, diabetic retinopathy, and lower-extremity amputation. Based on the predicted risk profile, diabetes educators used a standardized education manual to provide personalized education focused primarily on the complication with the highest predicted risk and relevant modifiable health behaviors. Participants continued to receive standard diabetes education and routine clinical care. Personalized education was provided at enrollment and repeated approximately 3 months later. At 6 months, complication-risk assessment and relevant clinical and patient-reported measures were reassessed.

Primary outcomes

  1. Change From Baseline in Hemoglobin A1c

    Time frame: Baseline and Month 6

    Change in hemoglobin A1c from baseline to the 6-month assessment, expressed in percentage points.

Other outcomes

  1. Change From Baseline in Systolic Blood Pressure

    Time frame: Baseline and Month 6

    Change in systolic blood pressure from baseline to the 6-month assessment, expressed in mmHg.

  2. Change From Baseline in Diastolic Blood Pressure

    Time frame: Baseline and Month 6

    Change in diastolic blood pressure from baseline to the 6-month assessment, expressed in mmHg.

  3. Change From Baseline in Body Weight

    Time frame: Baseline and Month 6

    Change in body weight from baseline to the 6-month assessment, expressed in kilograms.

  4. Change From Baseline in Total Cholesterol

    Time frame: Baseline and Month 6

    Change in serum total cholesterol from baseline to the 6-month assessment, expressed in mg/dL.

  5. Change From Baseline in Low-Density Lipoprotein Cholesterol

    Time frame: Baseline and Month 6

    Change in serum low-density lipoprotein cholesterol from baseline to the 6-month assessment, expressed in mg/dL.

  6. Change From Baseline in High-Density Lipoprotein Cholesterol

    Time frame: Baseline and Month 6

    Change in serum high-density lipoprotein cholesterol from baseline to the 6-month assessment, expressed in mg/dL.

  7. Change From Baseline in Triglycerides

    Time frame: Baseline and Month 6

    Change in serum triglyceride concentration from baseline to the 6-month assessment, expressed in mg/dL.

  8. Change From Baseline in Serum Creatinine

    Time frame: Baseline and Month 6

    Change in serum creatinine from baseline to the 6-month assessment, expressed in mg/dL.

  9. Change From Baseline in Urinary Albumin-to-Creatinine Ratio

    Time frame: Baseline and Month 6

    Change in urinary albumin-to-creatinine ratio from baseline to the 6-month assessment, expressed in mg/g.

  10. Change From Baseline in Medication Adherence Score

    Time frame: Baseline and Month 6

    Change in the 6-item self-reported medication adherence score from baseline to Month 6. Total scores range from 0 to 12, with higher scores indicating better medication adherence.

  11. Change From Baseline in Diabetes-Related Emotional Distress

    Time frame: Baseline and Month 6

    Change in the 8-item Problem Areas in Diabetes Short Form (PAID-SF-8) score from baseline to Month 6. Total scores range from 0 to 32, with higher scores indicating greater diabetes-related emotional distress.

  12. Change From Baseline in Dietary Quality Score

    Time frame: Baseline and Month 6

    Change in the study-specified 10-item dietary quality score from baseline to Month 6. Total scores range from 10 to 50, with lower scores indicating healthier dietary behaviors.

  13. Change From Baseline in Neuropathic Pain Score

    Time frame: Baseline and Month 6

    Change in Douleur Neuropathique 4 (DN4) score from baseline to Month 6. Total scores range from 0 to 10, with higher scores indicating a greater burden of neuropathic pain symptoms.

Sponsors and collaborators

Lead sponsor

Taiwanese Association of Diabetes Educators

Other

Collaborators

  • Chang Gung Memorial Hospital
  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • Mackay Memorial Hospital
  • National Cheng-Kung University Hospital
  • National Taiwan University Hospital
  • Taichung Veterans General Hospital

Registry information

Official study title

Precision Diabetes Education According to Diabetic Complication Risk Assessment Tool

Acronym: PDE

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 28, 2026
Registry last updated
Aug 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.